Compare Packaging Corporation of America (PKG) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Packaging Corporation of America vs Summit Therapeutics Inc — how do they compare? Packaging Corporation of America trades at $230.51 (market cap $20.49B), while Summit Therapeutics Inc trades at $17.59 (market cap $13.71B). The key difference: Packaging Corporation of America is the larger of the two by market cap, and Packaging Corporation of America pays a 2.61% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Packaging Corporation of America for 45 Days and Summit Therapeutics Inc for 16 Days on average.
| PKG | SMMT | |
|---|---|---|
Market Cap | $20.49B | $13.71B |
Volume | 493,499 | 6,173,057 |
Sector | Consumer Cyclical | Health |
52-Week High | $257.43 | $26.38 |
52-Week Low | $191.68 | $12.43 |
Typical Hold Time | 45 Days | 16 Days |
Enterprise Value | $24.30B | $13.04B |
Dividend Yield | 2.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Packaging Corporation of America (PKG) trades at $230.51, up 1.43% on the day, amid a bearish technical signal from moving averages and oscillators. Recent earnings show mixed results with Q2 2026 beating estimates but Q4 2025 missing, while revenue growth is projected from $9.0B in 2025 to $9.5B in 2026. The company maintains a solid dividend, declaring $1.50 per share payable in October 2026, and analyst consensus leans hold with a $272.43 price target.
PKG faces headwinds from cost pressures and negative net cash flow, but strong institutional interest and stable packaging demand offer support. Risks include margin compression and economic sensitivity, yet the stock's current discount to analyst targets presents a potential upside for patient investors focused on fundamental strength.
Summit Therapeutics (SMMT) trades at $17.59, down 2.01% on the day, amid mixed earnings performance but strong analyst support with a consensus price target of $29.33. The stock shows a bullish technical signal from moving averages, with key support at $17 and resistance at $18. Recent news highlights a major $2 billion strategic investment from AstraZeneca and expanded clinical collaborations, boosting investor optimism despite current negative profitability metrics.
The outlook for SMMT is heavily driven by clinical progress and partnerships, offering significant upside if drug trials succeed, but carries high risk due to substantial losses, negative cash flow from operations, and reliance on positive trial outcomes. Investors should weigh the potential rewards against the company's current financial health and execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
